Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
43.19
+0.20 (0.47%)
At close: Mar 28, 2025, 4:00 PM
44.47
+1.28 (2.97%)
After-hours: Mar 28, 2025, 5:20 PM EDT
Cytokinetics Employees
Cytokinetics had 498 employees as of December 31, 2024. The number of employees increased by 75 or 17.73% compared to the previous year.
Employees
498
Change (1Y)
75
Growth (1Y)
17.73%
Revenue / Employee
$37,096
Profits / Employee
-$1,183,787
Market Cap
5.11B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CYTK News
- 10 days ago - Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community - GlobeNewsWire
- 12 days ago - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo - GlobeNewsWire
- 14 days ago - Cytokinetics Nears Approval: 'Buy' The New Potential Cardiology Franchise With Aficamten - Seeking Alpha
- 27 days ago - Cytokinetics to Participate in March Investor Conferences - GlobeNewsWire
- 4 weeks ago - Cytokinetics, Incorporated (CYTK) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - 20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset' - Market Watch